A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms
Public ClinicalTrials.gov record NCT04430855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal and genital) regions. This study will evaluate how well upadacitinib compared to placebo (no medicine) works to treat hidradenitis suppurativa in adult participants with moderate to severe disease. The study will assess change in disease signs and symptoms.
Study identification
- NCT ID
- NCT04430855
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 68 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2020 (Actual)
- Primary completion
- Apr 22, 2021 (Actual)
- Completion
- Jan 25, 2022 (Actual)
- Last update posted
- Feb 6, 2023
2020 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialist /ID# 221084 | Phoenix | Arizona | 85006-2722 | — |
| University of Arkansas for Medical Sciences /ID# 218404 | Little Rock | Arkansas | 72205 | — |
| Medderm Associates /ID# 218317 | San Diego | California | 92103 | — |
| Skin Care Research - Boca Raton /ID# 218809 | Boca Raton | Florida | 33486-2269 | — |
| Lakes Research, LLC /ID# 218854 | Miami | Florida | 33014 | — |
| ForCare Clinical Research /ID# 218013 | Tampa | Florida | 33613-1244 | — |
| Northshore University Health System Dermatology Clinical Trials Unit /ID# 218319 | Skokie | Illinois | 60077 | — |
| Dawes Fretzin, LLC /ID# 218310 | Indianapolis | Indiana | 46256 | — |
| Beth Israel Deaconess Medical Center /ID# 218306 | Boston | Massachusetts | 02215-5400 | — |
| Washington University-School of Medicine /ID# 218331 | St Louis | Missouri | 63110 | — |
| Psoriasis Treatment Center of Central New Jersey /ID# 218330 | East Windsor | New Jersey | 08520 | — |
| Duke Cancer Center /ID# 218526 | Durham | North Carolina | 27710-3000 | — |
| University Hospitals Case Medical Center /ID# 218326 | Cleveland | Ohio | 44106 | — |
| Southside Dermatology /ID# 218321 | Tulsa | Oklahoma | 74132 | — |
| University of Pittsburgh MC /ID# 218329 | Pittsburgh | Pennsylvania | 15260 | — |
| Medical University of South Carolina /ID# 218318 | Charleston | South Carolina | 29425 | — |
| Duplicate_Center for Clinical Studies /ID# 218307 | Houston | Texas | 77004 | — |
| Dermatology Specialists of Spokane /ID# 218760 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04430855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2023 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04430855 live on ClinicalTrials.gov.